Vaccine escape in a heterogeneous population: insights for SARS-CoV-2 from a simple model
As a countermeasure to the SARS-CoV-2 pandemic, there has been swift development and clinical trial assessment of candidate vaccines, with subsequent deployment as part of mass vaccination campaigns. However, the SARS-CoV-2 virus has demonstrated the ability to mutate and develop variants, which can...
Autors principals: | Gog, JR, Hill, EM, Danon, L, Thompson, RN |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Royal Society
2021
|
Ítems similars
-
Vaccine escape in a heterogeneous population: insights for SARS-CoV-2 from a simple model
per: Julia R. Gog, et al.
Publicat: (2021-07-01) -
Conservation and Evolution of Antigenic Determinants of SARS-CoV-2: An Insight for Immune Escape and Vaccine Design
per: Varun Jaiswal, et al.
Publicat: (2022-04-01) -
A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations
per: Chiranjib Chakraborty, et al.
Publicat: (2022-02-01) -
SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
per: Danyi Ao, et al.
Publicat: (2022-03-01) -
Modeling the population effects of escape mutations in SARS-CoV-2 to guide vaccination strategies
per: James S. Koopman, et al.
Publicat: (2021-09-01)